MSB 3.83% $1.26 mesoblast limited

Cell Therapy News/Articles, page-10841

  1. 334 Posts.
    lightbulb Created with Sketch. 117

    -$0.16 EPS Expected for Mesoblast Limited (NASDAQ:MESO) This Quarter


    Equities analysts expect that Mesoblast Limited (NASDAQ:MESO) will post ($0.16) earnings per share for the current quarter, Zacks reports. Two analysts have made estimates for Mesoblast’s earnings, with the highest EPS estimate coming in at ($0.15) and the lowest estimate coming in at ($0.16). Mesoblast reported earnings per share of ($0.30) in the same quarter last year, which suggests a positive year-over-year growth rate of 46.7%. The business is expected to issue its next quarterly earnings report on Wednesday, September 1st.

    According to Zacks, analysts expect that Mesoblast will report full year earnings of ($0.65) per share for the current fiscal year, with EPS estimates ranging from ($0.90) to ($0.45). For the next year, analysts anticipate that the company will report earnings of ($0.49) per share, with EPS estimates ranging from ($0.71) to ($0.20). Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Mesoblast.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.